(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(0.12%) $82.73
(0.99%) $2.05
(-0.45%) $2 347.20
(-0.87%) $27.42
(-0.20%) $959.60
(-0.19%) $0.933
(-0.32%) $10.99
(-0.54%) $0.796
(1.56%) $93.31
0.77% INR 685.90
Live Chart Being Loaded With Signals
Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs...
Stats | |
---|---|
Dagens volum | 126 875 |
Gjennomsnittsvolum | 555 110 |
Markedsverdi | 109.25B |
EPS | INR0 ( 2024-02-01 ) |
Neste inntjeningsdato | ( INR0 ) 2024-05-27 |
Last Dividend | INR5.00 ( 2023-08-10 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 288.19 |
ATR14 | INR0.756 (0.11%) |
Volum Korrelasjon
Jubilant Pharmova Limited Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Jubilant Pharmova Limited Korrelasjon - Valuta/Råvare
Jubilant Pharmova Limited Økonomi
Annual | 2022 |
Omsetning: | INR62.19B |
Bruttogevinst: | INR43.41B (69.80 %) |
EPS: | INR-3.83 |
FY | 2022 |
Omsetning: | INR62.19B |
Bruttogevinst: | INR43.41B (69.80 %) |
EPS: | INR-3.83 |
FY | 2022 |
Omsetning: | INR60.59B |
Bruttogevinst: | INR42.72B (70.51 %) |
EPS: | INR26.00 |
FY | 2021 |
Omsetning: | INR59.64B |
Bruttogevinst: | INR42.10B (70.60 %) |
EPS: | INR52.48 |
Financial Reports:
No articles found.
Jubilant Pharmova Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR5.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR5.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.857 | 2003-09-18 |
Last Dividend | INR5.00 | 2023-08-10 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 22 | -- |
Total Paid Out | INR57.64 | -- |
Avg. Dividend % Per Year | 0.70% | -- |
Score | 1.6 | -- |
Div. Sustainability Score | 1.198 | |
Div.Growth Potential Score | 2.80 | |
Div. Directional Score | 1.999 | -- |
Year | Amount | Yield |
---|---|---|
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR3.00 | 0.37% |
2019 | INR4.50 | 0.63% |
2020 | INR5.00 | 0.94% |
2021 | INR5.00 | 0.78% |
2022 | INR5.00 | 0.85% |
2023 | INR5.00 | 1.38% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SILINV.NS | Dividend Junior | 2023-08-18 | Annually | 23 | 0.63% | |
MBAPL.NS | Dividend Junior | 2023-09-18 | Annually | 8 | 0.44% | |
GUJAPOLLO.NS | Ex Dividend Junior | 2023-09-22 | Annually | 18 | 0.48% | |
BAYERCROP.NS | Dividend Junior | 2023-08-03 | Annually | 15 | 1.25% | |
PREMIERPOL.NS | Dividend Junior | 2023-09-11 | Sporadic | 9 | 0.39% | |
KAMDHENU.NS | Dividend Junior | 2023-08-14 | Sporadic | 17 | 0.32% | |
EDELWEISS.NS | Dividend Junior | 2023-09-18 | Annually | 17 | 2.38% | |
ADSL.NS | Dividend Junior | 2023-08-10 | Sporadic | 16 | 0.91% | |
STERTOOLS.NS | Dividend Junior | 2023-09-11 | Annually | 19 | 0.38% | |
NAHARCAP.NS | No Dividend Player | 2023-09-08 | Annually | 17 | 0.70% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00577 | 1.500 | 9.88 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.00701 | 1.500 | -1.033 | -1.550 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 1.512 | 1.000 | -0.551 | -0.551 | [3 - 30] |
operatingCashFlowPerShareTTM | 35.50 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 35.50 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.673 | 1.000 | 2.11 | 2.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0588 | 1.000 | -0.825 | -0.825 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 1.198 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 287.75 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.00701 | 2.50 | -0.664 | -1.550 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 35.50 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.731 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 35.50 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -41.50 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0862 | 1.000 | -0.345 | 0 | [0.1 - 0.5] |
Total Score | 2.80 |
Jubilant Pharmova Limited
Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and solid dosage formulations, as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is headquartered in Noida, India.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.